Sona Nanotech Inc. (SNANF)
- Previous Close
0.3000 - Open
0.3043 - Bid --
- Ask --
- Day's Range
0.3000 - 0.3000 - 52 Week Range
0.1090 - 0.4080 - Volume
2,083 - Avg. Volume
4,175 - Market Cap (intraday)
30.373M - Beta (5Y Monthly) -1.67
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia therapy for cancer treatment; and nanomedical therapy for the treatment of colorectal cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; bovine TB tests; and concussion screening tests. Sona Nanotech Inc. was founded in 2013 and is based in Halifax, Canada.
www.sonanano.com--
Full Time Employees
October 31
Fiscal Year Ends
Sector
Industry
Recent News: SNANF
Performance Overview: SNANF
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNANF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNANF
Valuation Measures
Market Cap
30.48M
Enterprise Value
30.77M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
33.17
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-14.21
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-131.18%
Return on Equity (ttm)
-1,519.21%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.86M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
150.9k
Total Debt/Equity (mrq)
44.63%
Levered Free Cash Flow (ttm)
-638.59k
Research Analysis: SNANF
Company Insights: SNANF
SNANF does not have Company Insights